El Mathari Sulayman, Shehadeh Saadullah, Zwaan W Patrick, Boulidam Noor, Kuitert Lieke, Twisk Jos W R, Klautz Robert J M, de Lind van Wijngaarden Rob, Veen Kevin, Kluin Jolanda
Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eur J Cardiothorac Surg. 2024 Nov 28;66(6). doi: 10.1093/ejcts/ezae440.
The VRECOVERY investigated the impact of virtual reality (VR) distraction therapy on postoperative pain, anxiety and quality of recovery in patients undergoing coronary artery bypass grafting surgery.
A single-centre randomized controlled trial was conducted involving 192 participants, allocated to either the intervention or control group. Participants in the intervention group received VR distraction therapy on postoperative days 1, 2 and 3, while the control group received standard postoperative care. Primary outcomes were measured in both groups directly following the VR sessions of the intervention group. Outcomes included (i) postoperative pain [Numeric Rating Scale (NRS)], (ii) postoperative anxiety [State Trait Anxiety Inventory 6 questionnaire (STAI-6)] and (iii) quality of postoperative recovery [Quality of Recovery 15 questionnaire (QoR-15)].
A total of 100 participants completed the study, including 39 patients (mean age 69.1 ± 7.7 years) in the intervention group and 61 patients (mean age 66.8 ± 8.2 years) in the control group. Eighty-nine percent of participants was male. VR-distraction therapy demonstrated a significant difference in postoperative pain decrease between groups (NRS score; intervention group -1.45/day vs control group -0.73/day, P = 0.007), and an important overall difference in postoperative anxiety slopes (STAI-6 score; intervention group -0.60/day vs control group +0.09/day, P = 0.06). There was no effect observed on postoperative quality of recovery (P = 0.11).
The VRECOVERY trial suggests a beneficial impact of VR distraction therapy in reducing postoperative pain. There was no significant effect on postoperative anxiety and quality of recovery.
VRECOVERY研究了虚拟现实（VR）分散注意力疗法对冠状动脉搭桥手术患者术后疼痛、焦虑及恢复质量的影响。
进行了一项单中心随机对照试验，纳入192名参与者，分为干预组或对照组。干预组参与者在术后第1、2和3天接受VR分散注意力疗法，而对照组接受标准术后护理。在干预组的VR治疗结束后，直接对两组的主要结局进行测量。结局包括：（i）术后疼痛[数字评分量表（NRS）]，（ii）术后焦虑[状态-特质焦虑量表6问卷（STAI-6）]，以及（iii）术后恢复质量[恢复质量15问卷（QoR-15）]。
共有100名参与者完成了研究，其中干预组39例患者（平均年龄69.1±7.7岁），对照组61例患者（平均年龄66.8±8.2岁）。89%的参与者为男性。VR分散注意力疗法显示两组术后疼痛减轻存在显著差异（NRS评分；干预组-1.45/天，对照组-0.73/天，P=0.007），术后焦虑斜率也存在重要的总体差异（STAI-6评分；干预组-0.60/天，对照组+0.09/天，P=0.06）。未观察到对术后恢复质量的影响（P=0.11）。
VRECOVERY试验表明VR分散注意力疗法对减轻术后疼痛有有益影响。对术后焦虑和恢复质量无显著影响。
